In addition, a significant correlation between TAZ and GLUT1 expression was observed in the immunohistochemical analysis of clinical specimens (p < 0.01), suggesting that at least TAZ contributes to the progression of endometrial cancer by inducing GLUT1 expression. Here, SLC2A1 is linked to endometrial cancer.